$0.1818
0.00593.35%

The average analyst price target for AEON Biopharma is $3.47. Of 3 analysts, 3 rate it Buy. Targets range from $1.20 to $7.20. The latest change came on Oct 1, 2026, when Lake Street raised its price target on AEON Biopharma from $1 to $2 and kept a Buy rating.
Price Target Range — 6 Quarters
Analyst Consensus — 3 Analysts
Rating Trend — Last 9 Months